Allogene Therapeutics Reports Second Quarter 2020 Financial Results

Go back to Allogene Therapeutics Reports Second Quarter 2020 Financial Results
(NASDAQ: ALLO) Delayed: 2.09 -0.01 (0.48%)
Previous Close $2.10    52 Week High
Open $2.12    52 Week Low
Day High $2.15    P/E N/A 
Day Low $2.06    EPS
Volume 4,366,300